UnitedHealth Group, US91324P1021

UnitedHealth Group analyst views stay constructive, shares hold above 400 dollars on NYSE

23.06.2026 - 20:16:26 | ad-hoc-news.de

UnitedHealth Group opens the week with a solid analyst backdrop and a firm position in the Dow Jones. Price targets from Truist, Bernstein and JPMorgan underline a constructive view while the shares trade above 400 dollars on the NYSE.

UnitedHealth Group, US91324P1021
UnitedHealth Group, US91324P1021

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 20:15.

UnitedHealth Group (US91324P1021) enters the new week with a constructive analyst backdrop and a firm role in the Dow Jones Industrial Average. The shares recently changed hands at around 406 to 408 dollars on the NYSE, according to price data from MarketScreener and TrendSpider.MarketScreener overview for UnitedHealth

What recent analyst notes show

Several research houses have reiterated a constructive view on UnitedHealth Group in June, supporting the stock's standing within the S&P 500 and Dow Jones. Truist Securities maintained its Buy rating and raised its price target from 395 to 440 dollars, according to a recent analyst summary.TrendSpider analyst snapshot for UNH

Bernstein likewise keeps an Outperform rating in place and lifted its UnitedHealth price target from 444 to 492 dollars, adding to the positive sell-side stance on the stock.TrendSpider analyst snapshot for UNH On 8 June, JPMorgan also adjusted its target upward to 466 dollars from 420 dollars while maintaining an Overweight rating, according to a June research update summarized by MarketScreener.MarketScreener analyst and news overview

Consensus picture on Tuesday

On Tuesday, data from MarketScreener show UnitedHealth Group trading at 406.68 dollars at the 22 June close, with a modest gain of 1.43 percent and a roughly 23.7 percent advance since the beginning of the year, underlining a robust performance versus many healthcare peers.MarketScreener price and performance data

The stock also sits not far from its 52-week high of 415.96 dollars, according to TrendSpider, while the next earnings release is scheduled for 16 July 2026, keeping the upcoming quarterly numbers firmly on investor calendars.TrendSpider key metrics for UNH

Go deeper

All news and analysis on the UnitedHealth Group shares

Price data, ratings and corporate disclosures on UnitedHealth Group are collected in the dedicated topic section on ad-hoc-news.de and the company’s own investor relations pages.

How UnitedHealth Group earns its money

UnitedHealth Group operates with two primary business platforms: UnitedHealthcare, which provides health benefits and insurance coverage across commercial, Medicare and Medicaid markets, and Optum, which delivers health services, technology, pharmacy benefit management and care delivery solutions for payers, providers and governments.UnitedHealth Group investor information

Where the shares trade today

The UnitedHealth Group shares (US91324P1021) trade on 2026-06-22 at 406.68 dollars on the NYSE, based on MarketScreener closing data, with a 52-week range that extends up to roughly 415.96 dollars.MarketScreener closing quote for UNH

Key data on the UnitedHealth Group shares

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • WKN: 869561
  • Ticker: UNH
  • Trading venue: NYSE
  • Price (as of 2026-06-22, 22:00): 406.68 USD
  • Market cap: ~376 billion USD (as of 2026-06-22)
  • Sector / industry: Health Care / Managed Health Care
  • Index membership: Dow Jones Industrial Average, S&P 500, S&P 100
  • Next earnings date: 2026-07-16

More on the UnitedHealth Group shares in social media

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 69612902 | bgmi